The Vanguard S&P 500 ETF closed at 591.36 Monday, down 0.04%.
Bloomberg just reported — literal seconds ago — that the Trump Administration is discussing taking a 10% stake in Intel (Nasdaq: INTC). No details at present and the stock hasn’t had time to react much at all. In fact, it’s down 2.6% as of this moment.
The Voo is now down a fraction of a fraction of a percent — -0.04%.
Novo Nordisk (NYSE: NVO) has just won FDA approval to use its Wegovy GLP-1 weight loss drug to treat metabolic dysfunction-associated steatohepatitis (MASH) liver disease in adults. Novo also announced today price cuts on Ozempic for cash buyers, and a partnership with GoodRX that will lower Ozempic and Wegovy prices for drugs bought through that platform to $499 per month.
Novo Nordisk stock is up 5% in response.
MoffettNathanson analyst Robert Fishman started coverage on S&P 500 component company Live Nation Entertainment (NYSE: LYV) this morning, rating the stock a buy with a $195 price target. “Live Nation stands at the center of [the live concert] ecosystem,” says Fishman, and is the “largest live entertainment company in the world.” The stock is sitting at “essentially record highs” and is not cheap, but it’s nonetheless “well positioned for strong growth and outsized returns.”
Investors aren’t convinced. In the opening minutes of trading, Live Nation stock is down 0.4%. On the plus side, the Vanguard S&P 500 ETF is back up now to flat, with 0.00% change from Friday’s close.
Live coverage has ended. The full story is below.
This article will be updated throughout the day, so check back often for more daily updates.
The S&P 500 closed higher for the second week in a row Friday, with the Vanguard S&P 500 ETF (NYSEMKT: VOO) rising 1% for the week. Preparing for Monday’s open, however, the market looks set to take a breather, and is trading down 0.1% premarket.
Over the weekend, a meeting between Presidents Trump and Putin in Alaska ended with no clear accomplishments, and little improvement in hopes Russia’s war on Ukraine can be ended soon.
A little to the south and a little to the east, S&P 500 companies are starting to wind down their Q2 reports. 92% of S&P 500 companies have already reported earnings for the season, according to CNBC data, and 82% of S&P 500 companies have “beat earnings.”
There’s little in the way of “hot” earnings news this morning. E-commerce software company Riskified (NYSE: RSKD) reports this morning a surprise Q2 profit of $0.02 per share, where Wall Street expected a six-cent loss. Revenue of $81.1 million beat forecasts for $80 million in the quarter, and revenue guidance was sound.
Investors aren’t impressed, however, and Riskified stock is down more than 9% premarket.
In the absence of new earnings news, Wall Street analysts are using the time to update their analysis of earlier reports.
KeyBanc upgrades Duolingo (Nasdaq: DUOL | DUOL Price Prediction) to overweight with a $460 price target. “The AI backlash was a bump in the road, and a combination of product (e.g., Energy rollout, September Duocon updates) and viral marketing efforts creates upside risk to estimates over the next 12 months,” says KeyBanc.
(And by the way, “upside risk” is a good thing).
BMO Capital analyst Fadi Chamoun, meanwhile, is downgrading railroad company and S&P 500 component CSX (NYSE: CSX) to market perform, with a $38 price target. Despite seeing mergers & acquisitions activity in the railroad industry, Chamoun isn’t convinced CSX will be a target of such M&A activity, and cites the stock’s 20% rise in price on hopes it will be acquired as a negative for the stock rising further.
Contact [email protected] for any questions or corrections.
Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.
He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.
This article will be updated throughout the day, so check back often for more daily updates. Further details are leaking out regarding the weekend negotiations between U.S. and Chinese trade representatives, especially as regards…
This article will be updated throughout the day, so check back often for more daily updates. Since tumbling into bear market territory in April in response to a flurry of tariffs announcements from President…
This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) closed down 0.3% on Thursday as the U.S. government endured its…
Four names are drawing analyst attention this week, with TD Cowen stepping back from Novo Nordisk A/S (NYSE:NVO | NVO Price Prediction), Truist trimming its target on Korn Ferry (NYSE:KFY), Morgan Stanley adjusting expectations…
Two healthcare names are drawing fresh analyst attention this week as Wall Street recalibrates around a landmark GLP-1 truce and a fertility benefits company navigating a murky 2026 outlook. Barclays analyst Glen Santangelo raised…
This article will be updated throughout the day, so check back often for more daily updates. It’s a pretty slow news day on Wall Street so far, with most professional investors waiting to hear…
This article will be updated throughout the day, so check back often for more daily updates. It’s Day 2 of the Government Shutdown of 2025, and Treasury Secretary Scott Bessent is warning investors that…
This article will be updated throughout the day, so check back often for more daily updates. A tame inflation report set the stock market on fire yesterday, sending the Vanguard S&P 500 ETF (NYSEMKT:…
This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) came close to regaining its all-time high (hit just late last…
